443 related articles for article (PubMed ID: 31500113)
1. Gene Therapy for ALS-A Perspective.
Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113
[TBL] [Abstract][Full Text] [Related]
2. Approaches to Gene Modulation Therapy for ALS.
Meijboom KE; Brown RH
Neurotherapeutics; 2022 Jul; 19(4):1159-1179. PubMed ID: 36068427
[TBL] [Abstract][Full Text] [Related]
3. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.
Biferi MG; Cohen-Tannoudji M; Cappelletto A; Giroux B; Roda M; Astord S; Marais T; Bos C; Voit T; Ferry A; Barkats M
Mol Ther; 2017 Sep; 25(9):2038-2052. PubMed ID: 28663100
[TBL] [Abstract][Full Text] [Related]
4. Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy.
Cappella M; Pradat PF; Querin G; Biferi MG
J Neuromuscul Dis; 2021; 8(1):25-38. PubMed ID: 33074186
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
6. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
[TBL] [Abstract][Full Text] [Related]
7. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
8. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy in Amyotrophic Lateral Sclerosis.
Fang T; Je G; Pacut P; Keyhanian K; Gao J; Ghasemi M
Cells; 2022 Jun; 11(13):. PubMed ID: 35805149
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for ALS: A review.
Amado DA; Davidson BL
Mol Ther; 2021 Dec; 29(12):3345-3358. PubMed ID: 33839324
[TBL] [Abstract][Full Text] [Related]
11. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular Delivery in Mice for Motor Neuron Diseases.
Nizzardo M; Rizzuti M
Methods Mol Biol; 2017; 1565():229-239. PubMed ID: 28364247
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic tools for familial ALS.
Camu W; De La Cruz E; Esselin F
Rev Neurol (Paris); 2023; 179(1-2):49-53. PubMed ID: 36503675
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
15. [Familial Amyotrophic Lateral Sclerosis].
Suzuki N; Nishiyama A; Kato M; Warita H; Aoki M
Brain Nerve; 2019 Nov; 71(11):1169-1181. PubMed ID: 31722303
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapy for ALS: progress and prospects.
Azzouz M
Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.
Nowicka N; Juranek J; Juranek JK; Wojtkiewicz J
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31141951
[TBL] [Abstract][Full Text] [Related]
18. Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.
Nanou A; Higginbottom A; Valori CF; Wyles M; Ning K; Shaw P; Azzouz M
Mol Ther; 2013 Aug; 21(8):1486-96. PubMed ID: 23732987
[TBL] [Abstract][Full Text] [Related]
19. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
20. [Gene-specific treatment approaches in amyotrophic lateral sclerosis in the present and future].
Brenner D; Freischmidt A; Ludolph AC; Weishaupt JH
Nervenarzt; 2020 Apr; 91(4):287-293. PubMed ID: 32076756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
